跳至主要内容
临床试验/NL-OMON37244
NL-OMON37244已完成2 期

Remote ischemic preconditioning to reduce contrast-induced nephropathy. - RIPCIN study

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusioncriteria:
  • Interventions with expected intravascular contrast volume > 100 mL:
  • -Thoracic Endovascular Aortic Repair (TEVAR)
  • -Endovascular Aortic Repair (EVAR)
  • -Digital Substraction Angiography (DSA)
  • -Percutaneous Transluminal Angioplasty (PTA)
  • -Percutaneous Intentional Endovascular Revascularisation (PIER)
  • -Carotic Artery Stenting (CAS)
  • -Percutaneous coiling/embolisation procedures
  • -Computed Tomographic Angiography
  • High-risk of CIN (according CBO guideline):
  • - eGFR <45ml/min
  • - eGFR <60ml/min and diabetes
  • - eGFR <60ml/min ans 2 additional risk factors (peripheral artery disease, heart failure, >75 years, anaemia (Ht<0,39 for men and <0,36 for women), dehydration, use of diuretics and/or NSAID).;•Informed consent

排除标准

  • -Age < 18 years
  • -Hemo- and peritoneal dialysis
  • -Concomitant inclusion in another interventional study
  • -Percutaneous coiling/embolisation procedures of the kidney

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验